Boehringer Agrees to $650 Million Settlement of Pradaxa Lawsuit Claims
Boehringer Ingelheim has agreed to pay $650 million to resolve Pradaxa lawsuit claims over a medication suggested to cause episodes of serious internal bleeding, Forbes.com reports.
The “comprehensive settlement” will resolve about 4,000 cases now filed against the company, according to a statement issued on May 28th, and is geared towards off-setting a massive litigation involving the drug. Boehringer continues to defend the safety of Pradaxa, however, despite its alleged potential to cause instances of internal bleeding that may turn fatal.
“Notwithstanding our strong belief that we would prevail in these lawsuits, this settlement allows our company to avoid the distraction and uncertainty of protracted litigation over years and years,” a spokesperson for the company said.
Thousands of Pradaxa Bleeding Claims Filed in Four Years
What Boehringer can’t argue though, is that thousands of Pradaxa claims have been filed since its approval in 2010. Since being cleared by the U.S. Food and Drug Administration (FDA) for uses in lowering the risk for strokes in patients with atrial fibrillation, at least 2,400 lawsuits over the anticoagulant have joined a federal litigation underway in the U.S. District Court, Southern District of Illinois. According to Pradaxa bleeding lawsuits, there is no readily-available antidote for this side effect, which Boehringer failed to adequately warn patients about on its labeling.
The company’s decision to resolve lawsuits over the blood thinner is not the only bit of recent news likely to affect the nationwide Pradaxa lawsuit litigation. Earlier this month, Boehringer publicly acknowledged that the original clinical trial used to garner regulatory approval for the blood thinner may have left out a number of serious bleeding events. A press release on May 14th indicated that 22 adverse event reports of internal bleeding were omitted from the original trial report. This included five patients who took 150 mg doses of Pradaxa, 11 treated with a 110 mg dose, and six taking warfarin, a similar medication.
A report from 7 Action News in February reveals that this medication was also the most complained-about in the U.S., as per adverse event reports filed with the FDA during 2010 and 2011. Since its launch in October 2010, the federal agency has also received 1,158 reports of death allegedly caused by Pradaxa, and 12,494 injuries.
File a Pradaxa Lawsuit
Contact our Firm today to find out more about Pradaxa bleeding injuries, and whether you may be eligible to file a claim against Boehringer. Call us today at (877) 779-1414.